WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	292.53B
Revenue (ttm)	43.88B
Net Income (ttm)	14.99B
Shares Out	2.96B
EPS (ttm)	4.65
PE Ratio	19.42
Forward PE	16.04
Dividend	0.70 (0.71%)
Ex-Dividend Date	Sep 26, 2025

Volume	31,529,949
Average Volume	36,556,176
Open	98.68
Previous Close	98.17
Day's Range	97.02 - 101.00
52-Week Range	48.48 - 115.79
Beta	0.67
RSI	63.33
Earnings Date	Mar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.